Common clinical indications

• Acute treatment of migraine with or without aura in adults.
• Acute treatment of migraine with or without aura in adolescents ≥18 yr (adult dosing applies).
• Acute treatment of migraine in selected adolescents 12–17 yr when using combination sumatriptan/naproxen (Treximet), with caution and limited data.

Related drugs in this category

• Rizatriptan Benzoate · Rizatriptan benzoate

Frequently asked questions

What is Sumatriptan Succinate used for?

Sumatriptan Succinate (Sumatriptan succinate) is listed in YMed Atlas under Antimigraine agent, selective serotonin agonist. Indications, dosing, and safety information on this page summarize curated references—always confirm with current labeling, formularies, and local protocols.

How do I adjust dosing for renal impairment or special populations?

Review the dosing sections and references for this monograph. Many agents require renal or hepatic adjustment; pediatric, pregnancy, and lactation considerations are clinician-specific. This interface is educational and does not replace individualized prescribing decisions.

Is this medical advice?

No. YMed Atlas drug pages support learning and quick reference. They are not a substitute for clinical judgment, pharmacist review, or formal interaction checking with a complete medication list.